Levi & Korsinsky notifies investors that it has commenced an investigation into Waldencast plc (NASDAQ: WALD) concerning potential violations of the federal securities laws.
Waldencast issued a press release reporting its financial results for the second quarter of 2025 on November 24, 2025. The Company updated its financial outlook for the full year of 2025, expecting net revenue to be broadly in line with 2024 and adjusted EBITDA margin in the high single digits. Previously, Waldencast had guided to mid-teens net revenue growth and an adjusted EBITDA margin in the mid-to-high teens. The Company also reported a net loss of $185.2 million for the first half of 2025, primarily driven by impairment charges of $132.1 million and $20 million on its Obagi Medical and Milk Makeup brands, respectively. Following this news, Waldencast's share price fell over 6% on November 24, 2025.
If you suffered a loss on your Waldencast plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





